Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Very Strong
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Neutral
Dividends
Very Strong
Quality
Capital Efficiency
Strong
Balance Sheet
Very Strong
Telephone
61.2.9432.9400
Address
Level 22 161 Castlereagh Street Liberty Place Sydney, New South Wales (NSW) 2000
Description
Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Imaging, and Other. The Pathology segment provides pathology services. The Imaging segment focuses on imaging services from stand-alone imaging sites, hospitals, and medical centers. The Other segment consists of corporate functions. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leonards, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.08 - 2.53
Trade Value (12mth)
AU$916,372.00
1 week
1.5%
1 month
19.37%
YTD
2.11%
1 year
-31.92%
All time high
9.10
EPS 3 yr Growth
-1265.20%
EBITDA Margin
18.40%
Operating Cashflow
$238m
Free Cash Flow Return
8.80%
ROIC
-23.70%
Interest Coverage
4.50
Quick Ratio
0.40
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
20-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
5.74
Date | Announcements |
---|---|
05 September 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
03 September 24 |
Application for quotation of securities - HLS
×
Application for quotation of securities - HLS |
30 August 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
30 August 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
22 August 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
22 August 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
21 August 24 |
Preliminary Final Report
×
Preliminary Final Report |
21 August 24 |
HLS Release FY24 Results
×
HLS Release FY24 Results |
21 August 24 |
HLS FY24 Results Presentation
×
HLS FY24 Results Presentation |
16 August 24 |
Change in substantial holding
×
Change in substantial holding |
06 August 24 |
Replacement Appendix 3Y
×
Replacement Appendix 3Y |
06 August 24 |
Webcast details for FY 2024 Results
×
Webcast details for FY 2024 Results |
02 August 24 |
Resignation of Non-Executive Director
×
Resignation of Non-Executive Director |
02 August 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
16 July 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
15 July 24 |
Change in substantial holding
×
Change in substantial holding |
25 June 24 |
Healius announces Trading Update for FY 2024
×
Healius announces Trading Update for FY 2024 |
24 June 24 |
Change in substantial holding
×
Change in substantial holding |
14 June 24 |
Healius announces Group Executive of Pathology departure
×
Healius announces Group Executive of Pathology departure |
06 June 24 |
Change in substantial holding
×
Change in substantial holding |
06 June 24 |
Change in substantial holding from PPT
×
Change in substantial holding from PPT |
27 May 24 |
Update on Strategic Review and Chair Appointment
×
Update on Strategic Review and Chair Appointment |
23 May 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
17 May 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
17 May 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.